Telsey Advisory Group Reiterates “Outperform” Rating for Bath & Body Works (NYSE:BBWI)

Bath & Body Works (NYSE:BBWI)‘s stock had its “outperform” rating reaffirmed by analysts at Telsey Advisory Group in a research note issued to investors on Monday,Benzinga reports. They currently have a $42.00 price target on the stock. Telsey Advisory Group’s price target suggests a potential upside of 37.93% from the stock’s current price.

Other equities analysts have also issued reports about the stock. Wells Fargo & Company decreased their price objective on shares of Bath & Body Works from $35.00 to $32.00 and set an “equal weight” rating for the company in a research report on Wednesday, November 6th. Evercore ISI reduced their price target on shares of Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating for the company in a research report on Wednesday, August 28th. BMO Capital Markets reissued an “outperform” rating and set a $50.00 price target (down from $52.00) on shares of Bath & Body Works in a research report on Thursday, August 29th. Robert W. Baird reduced their price target on shares of Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating for the company in a research report on Thursday, August 29th. Finally, JPMorgan Chase & Co. reduced their price target on shares of Bath & Body Works from $42.00 to $39.00 and set a “neutral” rating for the company in a research report on Thursday, August 29th. One research analyst has rated the stock with a sell rating, six have given a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $42.44.

Bath & Body Works Stock Down 3.2 %

Shares of Bath & Body Works stock opened at $30.45 on Monday. The firm has a market capitalization of $6.67 billion, a P/E ratio of 7.37, a PEG ratio of 1.00 and a beta of 1.79. The company has a 50 day moving average price of $30.34 and a 200 day moving average price of $36.18. Bath & Body Works has a 52 week low of $26.20 and a 52 week high of $52.99.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.35 by $0.02. The firm had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.54 billion. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. As a group, research analysts anticipate that Bath & Body Works will post 3.18 earnings per share for the current fiscal year.

Insider Activity at Bath & Body Works

In other Bath & Body Works news, CEO Gina Boswell bought 6,000 shares of the stock in a transaction on Wednesday, October 9th. The shares were bought at an average price of $29.64 per share, with a total value of $177,840.00. Following the purchase, the chief executive officer now directly owns 242,987 shares in the company, valued at $7,202,134.68. This trade represents a 2.53 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.27% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Bath & Body Works

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. First Community Trust NA acquired a new stake in Bath & Body Works during the 2nd quarter worth $30,000. True Wealth Design LLC raised its holdings in shares of Bath & Body Works by 5,270.0% during the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock worth $34,000 after acquiring an additional 1,054 shares during the period. Livforsakringsbolaget Skandia Omsesidigt raised its holdings in shares of Bath & Body Works by 300.0% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock worth $38,000 after acquiring an additional 900 shares during the period. EntryPoint Capital LLC raised its holdings in shares of Bath & Body Works by 224.0% during the 1st quarter. EntryPoint Capital LLC now owns 1,471 shares of the company’s stock worth $74,000 after acquiring an additional 1,017 shares during the period. Finally, TD Private Client Wealth LLC raised its holdings in shares of Bath & Body Works by 24.2% during the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after acquiring an additional 331 shares during the period. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.